CIBC Private Wealth Group
EDIT icon

CIBC Private Wealth Group’s Editas Medicine EDIT Stock Holding History

CIBC Private Wealth Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$15K Hold
7,300
– – ﹤0.01% 2273
2025
Q3 		$25.3K Hold
7,300
– – ﹤0.01% 2071
2025
Q2 		$16.1K Hold
7,300
– – ﹤0.01% 2100
2025
Q1 		$7.16K Hold
7,300
– – ﹤0.01% 2347
2024
Q4 		$9.78K Sell
7,300
-750
-9% -$1.91K ﹤0.01% 2279
2024
Q3 		$27.5K Sell
8,050
-100
-1% -$435 ﹤0.01% 2018
2024
Q2 		$39.3K Buy
8,150
+850
+12% +$4.79K ﹤0.01% 1772
2024
Q1 		$53.1K Buy
+7,300
New +$60.7K ﹤0.01% 1651
2021
Q2 		– Sell
-5,120
Closed -$215K – 1035
2021
Q1 		$215K Buy
+5,120
New +$292K ﹤0.01% 980
2018
Q3 		– Sell
-310
Closed -$11K – 1159
2018
Q2 		$11K Sell
310
-1
-0.3% -$35 ﹤0.01% 1534
2018
Q1 		$10K Buy
+311
New +$11.1K ﹤0.01% 1529

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CIBC Private Wealth Group's EDIT Position: Q4 2025 in Review

CIBC Private Wealth Group held its Editas Medicine (EDIT) position steady in Q4 2025 at 7,300 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #2273.

CIBC Private Wealth Group first reported a position in EDIT in Q1 2018 and has held it in 11 quarters since. The position peaked at $215K in Q1 2021. 197 funds tracked by Wall St. Rank hold EDIT as of Q4 2025.

  • CIBC Private Wealth Group held 7,300 shares of Editas Medicine worth $15K as of Q4 2025.
  • CIBC Private Wealth Group left its Editas Medicine share count unchanged in Q4 2025.
  • Editas Medicine made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2273 holding.
  • CIBC Private Wealth Group first reported a position in Editas Medicine in Q1 2018 and has held it in 11 quarters since.
  • CIBC Private Wealth Group's Editas Medicine position peaked at $215K in Q1 2021.
  • 197 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.